Hoth Therapeutics Procures Full Licensing Rights for the BioLexa Platform for Treating Atopic Dermatitis

Hoth Therapeutics Inc announces that it has obtained exclusive worldwide licensing rights to the BioLexa Platform, a proprietary, patented antimicrobial therapy focused on treating atopic dermatitis.